NRAS and Miyoshi myopathy: To study the molecular bases that support the different behavior of patients carrying cNCoR and nNCoR tumors, we performed microarray expression analysis of invasive MM tumors with similar clinicopathologic characteristics and comparable mutational status for BRAF, NRAS and KIT (Table 2), which differ in the presence of cytoplasmic (n = 3) or nuclear (n = 4) NCoR.